Latest news
Loading news…
ILiAD Biotechnologies
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2012 11-50 employees For Profit
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
10
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- IT spend
- $473K
Company Info
- Founded
- 2012
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 38
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- -0.2
- Trend (90d)
- -2.2
- Last leadership hire
- Feb 10, 2026
Key People at ILiAD Biotechnologies
Executive Director
Founder and CEO
10
professional contacts at ILiAD Biotechnologies
Contact execs at ILiAD Biotechnologies →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ILiAD Biotechnologies
Loading news…
FAQs about ILiAD Biotechnologies
People who checked this page also checked these
Browse the full Acquirezy directory.